Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

Clinical trial NCT06532539 · RECRUITING

Trial details

NCT number: NCT06532539
Sponsor: Shandong Cancer Hospital and Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Endometrial Neoplasms Neoplasm Recurrence, Local Neoplasm Metastasis

Start date: 2024-06-13
Primary completion: 2026-08-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.